Clinical trial

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

NCT02473809

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-08-01

PhasePHASE4

Study timeline

Study start (unknown)2015-08-01Date precision: month

Registry last updated2018-09-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Complicationsunresolved

Osteoporosisunresolved

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

PlaceboDRUG

Sponsors & collaborators

University of Aarhuslead sponsor

Aarhus University Hospitalcollaborator

Novo Nordisk A/Scollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02473809 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.